| Views | |
|---|---|
| Anti‐KIT antibody, barzolvolimab, reduces skin mast cells and disease activity in chronic inducible urticaria | 34 |
| January 2025 | February 2025 | March 2025 | April 2025 | May 2025 | June 2025 | July 2025 | |
|---|---|---|---|---|---|---|---|
| Anti‐KIT antibody, barzolvolimab, reduces skin mast cells and disease activity in chronic inducible urticaria | 0 | 0 | 0 | 25 | 3 | 5 | 1 |
| Views | |
|---|---|
| 2022_Terhorst‐Molawi_etal.pdf | 18 |
